| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/13/2010 | CA2265500C Novel semaphorin gene: semaphorin y |
| 04/13/2010 | CA2244946C Gene expression vectors which generate an antigen specific immune response and methods of using the same |
| 04/13/2010 | CA2153593C Compositions and methods for delivery of genetic material |
| 04/13/2010 | CA2144056C Cd27 ligand |
| 04/08/2010 | WO2010040130A1 Methods for treatment and diagnosis of pulmonary diseases based on the expression of serca2 protein |
| 04/08/2010 | WO2010040112A2 Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1 |
| 04/08/2010 | WO2010039801A2 Methods of treating hepatitis c virus infection |
| 04/08/2010 | WO2010039778A2 Mammalian genes involved in infection |
| 04/08/2010 | WO2010039543A2 Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference |
| 04/08/2010 | WO2010038965A2 GCH1-TARGETED si RNA, RECOMBINANT VECTOR CONTAINING si RNA, AND PHARMACEUTICAL COMPOSITION CONTAINING RECOMBINANT VECTOR FOR TREATING AND PREVENTING NEUROPATHIC PAIN |
| 04/08/2010 | WO2010038756A1 PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN |
| 04/08/2010 | WO2010037224A1 Method for preventing and treating cardiovascular diseases with brca1 |
| 04/08/2010 | WO2010037181A1 Cell therapy and compositions therefor |
| 04/08/2010 | US20100087513 Microrna molecules |
| 04/08/2010 | US20100087512 Microrna molecules |
| 04/08/2010 | US20100087510 Novel Adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof |
| 04/08/2010 | US20100087509 Methods, Agents, and Compound Screening Assays for Inducing Differentiation of Undifferentiated Mammalian Cells into Osteoblasts |
| 04/08/2010 | US20100087507 Use of rpn2 gene expression inhibitor |
| 04/08/2010 | US20100087362 Use of biglycan or enhancers of biglycan activity in the preparation of pharmaceutical compositions |
| 04/08/2010 | US20100087335 siRNA targeting spleen tyrosine kinase |
| 04/08/2010 | US20100087001 Anti-angiogenic cellular agent for cancer therapy |
| 04/08/2010 | US20100086985 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 04/08/2010 | US20100086598 Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
| 04/08/2010 | US20100086565 Vectors for expression of hml-2 polypeptides |
| 04/08/2010 | CA2739464A1 Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1 |
| 04/07/2010 | EP2172560A2 stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 04/07/2010 | EP2172552A2 Recombinant nucleic acids comprising regions of AD6 |
| 04/07/2010 | EP2172551A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 04/07/2010 | EP2172476A2 Compositions and methods for WT1 specific immunotherapy |
| 04/07/2010 | EP2172226A1 Method of fixing and expressing physiologically active substance |
| 04/07/2010 | EP2172216A2 Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| 04/07/2010 | EP2172214A2 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 04/07/2010 | EP2172101A1 Normal-pressure glaucoma model and method of evaluating test substance by using the same |
| 04/07/2010 | EP2171448A2 Methods and agents for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells |
| 04/07/2010 | EP2170404A2 Compositions comprising human egfr-sirna and methods of use |
| 04/07/2010 | EP2170276A1 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 04/07/2010 | EP1240331B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/07/2010 | EP1175497B1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 04/07/2010 | CN1578647B Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues |
| 04/07/2010 | CN101690806A schistosomiasis japonica arborization carrier-DNA vaccine and preparation method thereof |
| 04/06/2010 | US7691998 siRNA targeting nucleoporin 62kDa (Nup62) |
| 04/06/2010 | US7691997 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing |
| 04/06/2010 | US7691995 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 04/06/2010 | US7691823 RIP140 regulation of glucose transport |
| 04/06/2010 | US7691822 Methods and compositions for treatment of interferon-resistant tumors |
| 04/06/2010 | US7691632 Kit for detecting the level of cyclin-dependent kinase inhibitor P16 gene expression |
| 04/06/2010 | US7691593 Regulation of lung tissue by patched therapeutics and formulations and uses related thereto |
| 04/06/2010 | US7691589 Effective as an anti-differentiator while the chicken differentiable cell is being cultured; enables stable supply of the LIF protein derived from chickens |
| 04/06/2010 | US7691395 BASB119 polypeptide and polynucleotide from Moraxella catarrhalis |
| 04/06/2010 | US7691390 polypeptide and isolated nucleic acid encoding the polypeptide for SARS CoV protein 3a, which can serve as a target for elucidating the mechanisms of SARS and developing vaccines and therapeutics |
| 04/06/2010 | US7691378 Treating carcinomas or adenocarcinomas using at least one anti-TNF (tumor necrosis factor) antibody |
| 04/06/2010 | US7691370 Selectivity replicating viral vector |
| 04/06/2010 | CA2453507C A controlled release biodegradable gel matrix |
| 04/06/2010 | CA2378925C Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 04/06/2010 | CA2280873C The use of latency associated peptide in wound healing |
| 04/06/2010 | CA2253243C Antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 04/06/2010 | CA2252466C Hepatitis b monoclonal antibodies |
| 04/06/2010 | CA2193491C Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| 04/01/2010 | WO2010037143A1 Vectors and methods of treating brain seizures |
| 04/01/2010 | WO2010036960A2 Methods for treating, diagnosing, and monitoring lupus |
| 04/01/2010 | WO2010034670A2 Host cell kinases as targets for antiviral therapies against hcv infection |
| 04/01/2010 | WO2010034314A1 Retroviral delivery of synthectic gene cassettes |
| 04/01/2010 | WO2010017378A3 Methods and compositions for vasculogenic potential determination |
| 04/01/2010 | WO2009151620A9 Pain treatment using erk2 inhibitors |
| 04/01/2010 | WO2009039743A8 Sirnas useful for inhibiting expression of tyrosinase gene, the compositions comprising the sirnas and their uses |
| 04/01/2010 | US20100081797 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 04/01/2010 | US20100081711 Cytotoxic agents |
| 04/01/2010 | US20100081202 Process for facilitating nucleic acid transfer |
| 04/01/2010 | US20100081193 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 04/01/2010 | US20100081192 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use |
| 04/01/2010 | US20100080844 Method to enhance an immune response of nucleic acid vaccination |
| 04/01/2010 | US20100080828 Immunogenic sequences |
| 04/01/2010 | US20100080813 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 04/01/2010 | US20100080778 Stem cell expansion enhancing factor and method of use |
| 04/01/2010 | US20100080776 Method of enhancing an immune response |
| 04/01/2010 | US20100080775 Recombinant adenoviruses encoding the specific iodine transporter (nis) |
| 04/01/2010 | CA2736373A1 Methods for treating, diagnosing, and monitoring lupus |
| 03/31/2010 | EP2169073A1 Vector for the preparation of immunotherapeutical compositions |
| 03/31/2010 | EP2169072A1 Multiple RNA polymerase III promoter expression constructs |
| 03/31/2010 | EP2169060A1 Novel polypeptide useful for diagnosis and treatment of cancer |
| 03/31/2010 | EP2168603A1 Therapeutic regimen for treating cancer |
| 03/31/2010 | EP2168598A1 Method of Treatment Using Ligand-Immunogen Conjugates |
| 03/31/2010 | EP2168596A2 Immunisation against chlamydia trachomatis |
| 03/31/2010 | EP2167138A2 Mir-34 regulated genes and pathways as targets for therapeutic intervention |
| 03/31/2010 | EP2167137A1 Hpv polyepitope constructs and uses thereof |
| 03/31/2010 | EP2167115A2 Treatment for alzheimer's disease |
| 03/31/2010 | EP1549353B1 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 03/31/2010 | EP1530724B1 Diagnosis and prevention of cancer cell invasion |
| 03/31/2010 | EP1278878B1 Codon optimized eiav vectors |
| 03/31/2010 | EP1194168B1 Methods and products for manipulating uncoupling protein expression |
| 03/31/2010 | EP1107989B1 Expression and export of angiostatin and endostatin as immunofusins |
| 03/31/2010 | CN101687025A Haemophilus influenzae type B |
| 03/31/2010 | CN101686990A Antiviral agent |
| 03/31/2010 | CN101684499A Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 03/31/2010 | CN101684477A Novel tumor target gene therapy system based on gland virus replication and recombination |
| 03/31/2010 | CN101684155A Nucleotide and protein sequences of nogo genes and methods based thereon |
| 03/31/2010 | CN101684146A Novel hcv non-structural polypeptide |
| 03/31/2010 | CN101683533A Gene transfer-mediated angiogenesis therapy |
| 03/31/2010 | CN101683518A Application of FHL 1 in preparing medicament for treating tumour |
| 03/31/2010 | CN101683354A Liver damage relevant drug target and application thereof |